| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine (D.G.O., S.D., C.F.-B., K.L.J., J.H.M., J.M.W., M.H.), University of Adelaide, Royal Adelaide Hospital; and Division of Clinical Biochemistry (H.A.M.), Institute of Medical and Veterinary Science, Adelaide, South Australia, Australia, 5000
Address all correspondence and requests for reprints to: Professor Michael Horowitz, University of Adelaide, Department of Medicine, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000, Australia. E-mail: michael.horowitz{at}adelaide.edu.au.
The determinants of postprandial blood glycemia are controversial. We assessed the effects of variations in the initial rate of small intestinal glucose delivery on blood glucose, plasma insulin, and incretin responses in both health and type 2 diabetes. Eight controls and eight patients with type 2 diabetes managed by diet alone underwent paired studies. On both days subjects received an intraduodenal glucose infusion (t = 0120 min); on one day the infusion rate was variable, being more rapid initially (3 kcal/min) between t = 0 and 15 min and slower (0.71 kcal/min) subsequently (t = 15120 min), whereas on the other day, the infusion rate was constant (1 kcal/min) from t = 0 to 120 min (i.e. on both days 120 kcal of glucose were administered). Between t = 0180 min blood glucose, plasma insulin and plasma glucose-dependent insulin-releasing polypeptide were greater with the variable, compared with the constant, infusion. Between t = 0 and 30 min the magnitude of the rise in plasma glucagon-like peptide-1 was greater with the variable, compared with the constant infusion (P < 0.01, both groups). We conclude that modest variations in the initial rate of duodenal glucose entry may have profound effects on subsequent glycemic, insulin, and incretin responses.
This work was supported by project grants from the Royal Adelaide Hospital and the National Health and Medical Research Council (NH&MRC) of Australia. K.L.J.s salary is derived from a fellowship jointly awarded by the NH&MRC and Diabetes Australia. C.F.-B.s salary is provided by a Career Development Award from the NH&MRC.
Abbreviations: GIP, Glucose-dependent insulin-releasing polypeptide; GLP-1, glucagon-like peptide-1; TMPD, transmucosal potential difference.
This article has been cited by other articles:
![]() |
M. Salehi, B. A. Aulinger, and D. A. D'Alessio Targeting {beta}-Cell Mass in Type 2 Diabetes: Promise and Limitations of New Drugs Based on Incretins Endocr. Rev., May 1, 2008; 29(3): 367 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Karamanlis, R. Chaikomin, S. Doran, M. Bellon, F D. Bartholomeusz, J. M Wishart, K. L Jones, M. Horowitz, and C. K Rayner Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1364 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vernaleken, M. Veyhl, V. Gorboulev, G. Kottra, D. Palm, B.-C. Burckhardt, G. Burckhardt, R. Pipkorn, N. Beier, C. van Amsterdam, et al. Tripeptides of RS1 (RSC1A1) Inhibit a Monosaccharide-dependent Exocytotic Pathway of Na+-D-Glucose Cotransporter SGLT1 with High Affinity J. Biol. Chem., September 28, 2007; 282(39): 28501 - 28513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Pilichiewicz, R. Chaikomin, I. M. Brennan, J. M. Wishart, C. K. Rayner, K. L. Jones, A. J. P. M. Smout, M. Horowitz, and C. Feinle-Bisset Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E743 - E753. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chaikomin, K. L. Wu, S. Doran, K. L. Jones, A. J. P. M. Smout, W. Renooij, R. H. Holloway, J. H. Meyer, M. Horowitz, and C. K. Rayner Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1099 - G1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Veyhl, T. Keller, V. Gorboulev, A. Vernaleken, and H. Koepsell RS1 (RSC1A1) regulates the exocytotic pathway of Na+-D-glucose cotransporter SGLT1 Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1213 - F1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Little, S. Doran, J. H. Meyer, A. J. P. M. Smout, D. G. O'Donovan, K.-L. Wu, K. L. Jones, J. Wishart, C. K. Rayner, M. Horowitz, et al. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E647 - E655. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gentilcore, R. Chaikomin, K. L. Jones, A. Russo, C. Feinle-Bisset, J. M. Wishart, C. K. Rayner, and M. Horowitz Effects of Fat on Gastric Emptying of and the Glycemic, Insulin, and Incretin Responses to a Carbohydrate Meal in Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2062 - 2067. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Wachters-Hagedoorn, M. G. Priebe, J. A. J. Heimweg, A. M. Heiner, K. N. Englyst, Jens. J. Holst, F. Stellaard, and R. J. Vonk The Rate of Intestinal Glucose Absorption Is Correlated with Plasma Glucose-Dependent Insulinotropic Polypeptide Concentrations in Healthy Men J. Nutr., June 1, 2006; 136(6): 1511 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Little, A. N. Pilichiewicz, A. Russo, L. Phillips, K. L. Jones, M. A. Nauck, J. Wishart, M. Horowitz, and C. Feinle-Bisset Effects of Intravenous Glucagon-Like Peptide-1 on Gastric Emptying and Intragastric Distribution in Healthy Subjects: Relationships with Postprandial Glycemic and Insulinemic Responses J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1916 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Horowitz and M A Nauck To be or not to be--an incretin or enterogastrone? Gut, February 1, 2006; 55(2): 148 - 150. [Full Text] [PDF] |
||||
![]() |
J Schirra, M Nicolaus, R Roggel, M Katschinski, M Storr, H J Woerle, and B Goke Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans Gut, February 1, 2006; 55(2): 243 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Kellett and E. Brot-Laroche Apical GLUT2: A Major Pathway of Intestinal Sugar Absorption Diabetes, October 1, 2005; 54(10): 3056 - 3062. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chaikomin, S. Doran, K. L. Jones, C. Feinle-Bisset, D. O'Donovan, C. K. Rayner, and M. Horowitz Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E504 - E507. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Russo, J. E. Stevens, R. Chen, D. Gentilcore, R. Burnet, M. Horowitz, and K. L. Jones Insulin-Induced Hypoglycemia Accelerates Gastric Emptying of Solids and Liquids in Long-Standing Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4489 - 4495. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Jones, D. O'Donovan, A. Russo, J. H. Meyer, J. E. Stevens, Y. Lei, J. Keogh, A. Tonkin, and M. Horowitz Effects of drink volume and glucose load on gastric emptying and postprandial blood pressure in healthy older subjects Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G240 - G248. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Meier, G. Kemmeries, J. J. Holst, and M. A. Nauck Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy Subjects Diabetes, July 1, 2005; 54(7): 2212 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gentilcore, R. Visvanathan, A. Russo, R. Chaikomin, J. E. Stevens, J. M. Wishart, A. Tonkin, M. Horowitz, and K. L. Jones Role of nitric oxide mechanisms in gastric emptying of, and the blood pressure and glycemic responses to, oral glucose in healthy older subjects Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1227 - G1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Horowitz, C. Feinle-Bisset, K. Jones, and M. Nauck Orlistat Augments Postprandial Increases in Glucagon-Like Peptide-1 in Obese Type 2 Diabetic Patients: Response to Damci et al. Diabetes Care, November 1, 2004; 27(11): 2770 - 2770. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |